HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 83 filers reported holding HARVARD BIOSCIENCE INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $933 | -98.5% | 217 | -98.1% | 0.00% | – |
| Q2 2023 | $63,953 | +6295.3% | 11,649 | +2258.1% | 0.00% | – |
| Q3 2022 | $1,000 | -75.0% | 494 | -51.9% | 0.00% | – |
| Q2 2022 | $4,000 | -73.3% | 1,028 | -56.0% | 0.00% | – |
| Q1 2022 | $15,000 | -81.2% | 2,339 | -79.4% | 0.00% | – |
| Q4 2021 | $80,000 | +158.1% | 11,353 | +151.6% | 0.00% | – |
| Q3 2021 | $31,000 | +106.7% | 4,512 | +146.3% | 0.00% | – |
| Q2 2021 | $15,000 | +7.1% | 1,832 | -27.7% | 0.00% | – |
| Q1 2021 | $14,000 | -54.8% | 2,533 | -64.7% | 0.00% | – |
| Q4 2020 | $31,000 | +416.7% | 7,177 | +290.3% | 0.00% | – |
| Q3 2020 | $6,000 | -60.0% | 1,839 | -62.9% | 0.00% | – |
| Q2 2020 | $15,000 | -16.7% | 4,952 | -39.3% | 0.00% | – |
| Q1 2020 | $18,000 | -56.1% | 8,160 | -40.0% | 0.00% | – |
| Q4 2019 | $41,000 | +215.4% | 13,600 | +231.2% | 0.00% | – |
| Q3 2019 | $13,000 | -73.5% | 4,106 | -83.2% | 0.00% | – |
| Q2 2019 | $49,000 | +19.5% | 24,423 | +155.7% | 0.00% | – |
| Q1 2019 | $41,000 | +46.4% | 9,552 | +7.6% | 0.00% | – |
| Q4 2018 | $28,000 | -45.1% | 8,874 | -9.5% | 0.00% | – |
| Q3 2018 | $51,000 | +37.8% | 9,809 | +41.5% | 0.00% | – |
| Q2 2018 | $37,000 | -57.0% | 6,930 | -75.5% | 0.00% | – |
| Q1 2016 | $86,000 | +126.3% | 28,237 | +161.5% | 0.00% | – |
| Q4 2015 | $38,000 | +1800.0% | 10,797 | +2626.5% | 0.00% | – |
| Q3 2015 | $2,000 | -33.3% | 396 | -40.7% | 0.00% | – |
| Q2 2015 | $3,000 | +200.0% | 668 | +209.3% | 0.00% | – |
| Q1 2015 | $1,000 | 0.0% | 216 | -8.5% | 0.00% | – |
| Q4 2014 | $1,000 | 0.0% | 236 | -13.9% | 0.00% | – |
| Q3 2014 | $1,000 | 0.0% | 274 | -6.5% | 0.00% | – |
| Q2 2014 | $1,000 | -95.2% | 293 | -93.2% | 0.00% | – |
| Q1 2014 | $21,000 | -54.3% | 4,326 | -56.2% | 0.00% | – |
| Q4 2013 | $46,000 | +91.7% | 9,880 | +115.1% | 0.00% | – |
| Q3 2013 | $24,000 | -52.9% | 4,593 | -57.2% | 0.00% | – |
| Q2 2013 | $51,000 | – | 10,732 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 1,020,036 | $7,120,000 | 5.32% |
| Portolan Capital Management | 2,358,010 | $16,459,000 | 1.20% |
| Acuitas Investments, LLC | 375,836 | $2,623,000 | 1.14% |
| Parkman Healthcare Partners LLC | 475,367 | $3,318,000 | 0.84% |
| Adirondack Research & Management Inc. | 90,020 | $628,000 | 0.76% |
| Archon Capital Management LLC | 736,236 | $5,139,000 | 0.73% |
| BARD ASSOCIATES INC | 294,697 | $2,057,000 | 0.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,621,775 | $11,320,000 | 0.65% |
| GLOBEFLEX CAPITAL L P | 268,466 | $1,874,000 | 0.41% |
| Monarch Partners Asset Management LLC | 330,083 | $2,304,000 | 0.34% |